| 1301/1664 | US=2 / Mama Hawes D, Cote RJ. Predictive biomarkers in body fluids: detection of early tumor dissemination in patients with breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 293-321. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; DETECCAO DE DISSEMINACAO DO TUMOR PRECOCE; CANCER DE MAMA; MEDULA OSSEA; CELULAS TUMORAIS CIRCULANTES; DISSEMINACAO DO TUMOR NO INICIO; CITOMETRIA DE FLUXO; IMUNO-HISTOQUIMICA; SEPARACAO IMUNO-MAGNETICA; LINFONODOS; MICROMETASTASES; METASTASES OCULTAS; SANGUE PERIFERICO; REACAO REVERSA DA CADEIA DE TRANSCRIPTASE-POLIMERASE; LINFONODO SENTINELA |
| 1302/1664 | US=20-A / Cirurgia Andtbacka RHI, Meric-Bernstam F, Robinson EK, Hunt KK. Noninvasive breast cancer. In: Feig BW, Berger DH, Fuhrman GM. The M.D. Anderson surgical oncology oncology handbook. 4ª ed. Philadelphia: Lippincott Willians & Wilkins, 2006. p. 1-22. ISBN 978-0-7817-5643-3. CANCER DE MAMA NAO-INVASIVO; CARCINOMA DUCTAL IN SITU; CARCINOMA LOBULAR IN SITU |
| 1303/1664 | US=20-A / Cirurgia Zager JS, Solorzano CC, Thomas E, Feig BW, Babiera GV. Invasive breast cancer. In: Feig BW, Berger DH, Fuhrman GM. The M.D. Anderson surgical oncology oncology handbook. 4ª ed. Philadelphia: Lippincott Willians & Wilkins, 2006. p. 23-59. ISBN 978-0-7817-5643-3. CANCER DE MAMA INVASIVO; CANCER DE MAMA LOCALMENTE AVANCADO; CANCER DE MAMA INFLAMATORIO |
| 1304/1664 | US=20-A / Cirurgia Feledy JA Jr, Hanasono MM, Robb GL. Reconstructive surgery in the cancer patient. In: Feig BW, Berger DH, Fuhrman GM. The M.D. Anderson surgical oncology oncology handbook. 4ª ed. Philadelphia: Lippincott Willians & Wilkins, 2006. p. 635-49. ISBN 978-0-7817-5643-3. CANCER; CIRURGIA RECONSTRUTIVA; RECONSTRUCAO DE CABECA E PESCOCO; RECONSTRUCAO DA MAMA; RECONSTRUCAO DO TRONCO; RECONSTRUCAO DO PERINEO |
| 1305/1664 | US=32 / Biol/Mol Knudsen S. Breast cancer. In: ___. Cancer diagnostics with DNA microarrays. New Jersey: John Wiley & Sons, 2006. p. 87-96. ISBN 978-0-471-78407-4. |
| 1306/1664 | US=37 / Câncer Beuth J. Proteolytic enzymes. In: Beuth J, Moss RW. Complementary oncology: adjunctive methods in the treatment of cancer. New York: Thieme, 2006. p. 183-8. ISBN 978-1-5889-0323-0. CANCER; ONCOLOGIA; MEDICINA COMPLEMENTAR; ENZIMAS PROTEOLITICAS; EXAMES FARMACOLOGICOS; ESTUDOS EXPERIMENTAIS; ESTUDOS CLINICOS; PLASMOCITOMA; CANCER DE MAMA; CANCER COLORRETAL |
| 1307/1664 | US=45 / Urologia Barthelmes L, Gateley CA. What can we learn from breast cancer?. In: Bowsher W, Carter A. Challenges in prostate cancer. 2nd ed. Oxford: Blackwell Science, 2006. p. 17-25. ISBN 978-1-4051-0752-9. CANCER DE PROSTATA; CANCER DE MAMA; CANCER DE MAMA. PROGNOSTICO; CANCER DE MAMA. EPIDEMIOLOGIA; CANCER DE MAMA. GENETICA; CANCER DE MAMA. TERAPIA CIRURGICA; CANCER DE MAMA. TRIAGEM |
| 1308/1664 | US=47 / Clín/Medica Assis S, Hilakivi-Clarke L. Timing of dietary estrogenic exposures and breast cancer risk. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 14-35. ISBN 978-1-57331-699-5. EXPOSICOES ESTROGENICOS DIETETICOS; RISCO DE CANCER DE MAMA; CANCER DE MAMA; ESTROGENIOS; DIETA; TEMPO DE EXPOSICAO |
| 1309/1664 | US=47 / Imagem Verhey LJ, Chuang C, Pirzkall A. Magnetic resonance imaging for IMRT. In: Bortfeld T, Schmidt-Ulrich R, de Neve W, Wazer DE. Image-Guided IMRT. Berlin: Springer, 2006. p. 177-86. ISBN 3-540-20511-X. RADIOTERAPIA DE INTENSIDADE MODULADA; RESSONANCIA MAGNETICA; CANCER DE CABECA E PESCOCO; CANCER DE MAMA; CANCER DE PULMAO; CANCER DE PROSTATA |
| 1310/1664 | US=47 / Clín/Medica Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, Macaluso MC, Giacalone A, Di Noto L, Bongiovanni A, Candore G, Caruso C, Lio D, Palmeri S. Cytokine gene polymorphisms and breast cancer susceptibility. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 104-9. ISBN 978-1-57331-699-5. |
| 1311/1664 | US=47 / Clín/Medica Berrino F, Villarini A, Petris M, Raimondi M, Pasanisi P. Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 110-8. ISBN 978-1-57331-699-5. |
| 1312/1664 | US=47 / Clín/Medica Buck MB, Knabbe C. TGF-Beta signaling in breast cancer. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 119-26. ISBN 978-1-57331-699-5. ANTIESTROGENEO; TGF-BETA; CANCER DE MAMA; INIBICAO DO CRESCIMENTO; METASTASE |
| 1313/1664 | US=47 / Clín/Medica Vogel VG. Recent results from clinical trials using SERMs to reduce the risk of breast cancer. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 127-42. ISBN 978-1-57331-699-5. NEOPLASIAS DA MAMA; AVALIACAO DE RISCO; PREVENCAO; TAMOXIFEN; RALOXIFENO; HORMONIOS ESTEROIDES GONADAIS |
| 1314/1664 | US=47 / Imagem Arthur DW, Morris MM, Vicini FA, Dogan N. Breast IMRT. In: Bortfeld T, Schmidt-Ulrich R, de Neve W, Wazer DE. Image-Guided IMRT. Berlin: Springer, 2006. p. 371-81. ISBN 3-540-20511-X. |
| 1315/1664 | US=47 / Clín/Medica Ponzone R, Biglia N, Jacomuzzi ME, Mariani L, Dominguez A, Sismondi P. Antihormones in prevention and treatment of breast cancer. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 143-58. ISBN 978-1-57331-699-5. ESTROGENIOS; DOENCA AUTO-IMUNE; MAMA; CANCER; ENDOCRINO; TRATAMENTO; PREVENCAO |
| 1316/1664 | US=47 / Clín/Medica Traina A, Agostara B, Marasa L, Calabro M, Zarcone M, Carruba G. HER2/neu expression. in relation to clinicopathologic features of breast câncer patients. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 159-67. ISBN 978-1-57331-699-5. |
| 1317/1664 | US=47 / Clín/Medica Harkonen PL, Vaananen HK. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 218-27. ISBN 978-1-57331-699-5. ESTROGENIO; RECEPTOR DE ESTROGENO; MODULADOR SELETIVO DO RECEPTOR DE ESTROGENO; OSTEOCLASTOS; CELULAS DENDRITICAS; MICROGLIA; MACROFAGOS ASSOCIADOS A TUMORES; CANCER DE MAMA; CANCER DE PROSTATA |
| 1318/1664 | US=47 / Clín/Medica Hong Y, Chen S. Aromatase inhibitors: structural features and biochemical characterization. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 237-51. ISBN 978-1-57331-699-5. INIBIDORES DA AROMATASE; CANCER DE MAMA; INIBIDORES DE AROMATASE; FLAVONOIDE FITOESTROGENO; INIBIDOR BASEADO NO MECANISMO; MODELO STRCTURAL |
| 1319/1664 | US=49-A / Câncer Choudhury A, Mosolits S, Kokhaei P, Hansson L, Palma M, Mellstedt H. Clinical results of vaccine therapy for cancer: learning from history for improving the future. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2006. p. 147-202. ISBN 978-0-12-006695-7. CANCER; VACINA; RESULTADOS CLINICOS; DOENCAS DE CELULAS B; ENSAIOS DE VACINAS; LEUCEMIA LINFOCITICA CRONICA DE CELULAS B; MIELOMA MULTIPLO; CARCINOMA DE CELULAS RENAIS; CANCER DE PROSTATA; MELANOMA; CANCER GASTROINTESTINAL; CANCER GINECOLOGICO; CANCER DE PULMAO; CANCER DE MAMA |
| 1320/1664 | US=5 / Câncer Bower M, Waxman J. Tipos de cancro: cancro da mama. In: ___. Compêndio de oncologia. Lisboa: Piaget, 2006. p. 77-82. ISBN 972-771-961-7. CANCRO DA MAMA; DOENCAS DA MAMA; TERAPIA HORMONAL; DOENCAS DE PAGET DO MAMILO; CARCINOMA IN SITU |